144 related articles for article (PubMed ID: 15620460)
1. Responses in vitro of peripheral blood lymphocytes from patients with myasthenia gravis to stimulation with human acetylcholine receptor alpha-chain peptides: analysis in relation to age, thymic abnormality, and ethnicity.
Oshima M; Deitiker PR; Mosier DR; Smith RG; Atassi MZ
Hum Immunol; 2005 Jan; 66(1):32-42. PubMed ID: 15620460
[TBL] [Abstract][Full Text] [Related]
2. Subtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravis.
Deitiker PR; Oshima M; Smith RG; Mosier DR; Atassi MZ
Autoimmunity; 2006 Jun; 39(4):277-88. PubMed ID: 16891216
[TBL] [Abstract][Full Text] [Related]
3. T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients.
Oshima M; Deitiker PR; Smith RG; Mosier D; Atassi MZ
Autoimmunity; 2012 Mar; 45(2):153-60. PubMed ID: 21985279
[TBL] [Abstract][Full Text] [Related]
4. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
[TBL] [Abstract][Full Text] [Related]
5. A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.
Harcourt GC; Sommer N; Rothbard J; Willcox HN; Newsom-Davis J
J Clin Invest; 1988 Oct; 82(4):1295-300. PubMed ID: 2459161
[TBL] [Abstract][Full Text] [Related]
6. Myasthenia gravis patients, but not healthy subjects, recognize epitopes that are unique to the epsilon-subunit of the acetylcholine receptor.
Ragheb S; Mohamed M; Lisak RP
J Neuroimmunol; 2005 Feb; 159(1-2):137-45. PubMed ID: 15652413
[TBL] [Abstract][Full Text] [Related]
7. Response of CD4+ T cells from myasthenic patients and healthy subjects of biosynthetic and synthetic sequences of the nicotinic acetylcholine receptor.
Diethelm-Okita B; Wells GB; Kuryatov A; Okita D; Howard J; Lindstrom JM; Conti-Fine BM
J Autoimmun; 1998 Apr; 11(2):191-203. PubMed ID: 9650099
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the alpha subunit.
Oshima M; Ashizawa T; Pollack MS; Atassi MZ
Eur J Immunol; 1990 Dec; 20(12):2563-9. PubMed ID: 2269324
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis.
Dayan M; Sthoeger Z; Neiman A; Abarbanel J; Sela M; Mozes E
Hum Immunol; 2004 Jun; 65(6):571-7. PubMed ID: 15219376
[TBL] [Abstract][Full Text] [Related]
10. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor.
Matsuo H; Batocchi AP; Hawke S; Nicolle M; Jacobson L; Vincent A; Newsom-Davis J; Willcox N
J Immunol; 1995 Oct; 155(7):3683-92. PubMed ID: 7561069
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor expression and differential proliferative responses by T cells specific to a myasthenogenic peptide.
Kirshner SL; Waisman A; Zisman E; Ben-Nun A; Mozes E
Cell Immunol; 1997 Aug; 180(1):20-8. PubMed ID: 9316635
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides.
Atassi MZ; Oshima M
Crit Rev Immunol; 1997; 17(5-6):481-95. PubMed ID: 9419435
[TBL] [Abstract][Full Text] [Related]
13. Myasthenia gravis. Residues of the alpha and gamma subunits of muscle acetylcholine receptor involved in formation of immunodominant CD4+ epitopes.
Moiola L; Protti MP; McCormick D; Howard JF; Conti-Tronconi BM
J Immunol; 1994 May; 152(9):4686-98. PubMed ID: 7908921
[TBL] [Abstract][Full Text] [Related]
14. In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes.
Brocke S; Brautbar C; Steinman L; Abramsky O; Rothbard J; Neumann D; Fuchs S; Mozes E
J Clin Invest; 1988 Dec; 82(6):1894-900. PubMed ID: 2461962
[TBL] [Abstract][Full Text] [Related]
15. The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit.
Brocke S; Dayan M; Rothbard J; Fuchs S; Mozes E
Immunology; 1990 Apr; 69(4):495-500. PubMed ID: 1692300
[TBL] [Abstract][Full Text] [Related]
16. CD4+ T cell response to the human acetylcholine receptor alpha subunit in myasthenia gravis. A study with synthetic peptides.
Protti MP; Manfredi AA; Straub C; Howard JF; Conti-Tronconi BM
J Immunol; 1990 Feb; 144(4):1276-81. PubMed ID: 1968078
[TBL] [Abstract][Full Text] [Related]
17. T-cell antigenic sites involved in myasthenia gravis: correlations with antibody titre and disease severity.
Berrih-Aknin S; Cohen-Kaminsky S; Lepage V; Neumann D; Bach JF; Fuchs S
J Autoimmun; 1991 Feb; 4(1):137-53. PubMed ID: 2031657
[TBL] [Abstract][Full Text] [Related]
18. Use of synthetic peptides to establish anti-human acetylcholine receptor CD4+ cell lines from myasthenia gravis patients.
Protti MP; Manfredi AA; Straub C; Wu XD; Howard JF; Conti-Tronconi BM
J Immunol; 1990 Mar; 144(5):1711-20. PubMed ID: 1968487
[TBL] [Abstract][Full Text] [Related]
19. Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes.
Richman DP; Patrick J; Arnason BG
N Engl J Med; 1976 Mar; 294(13):694-8. PubMed ID: 129705
[TBL] [Abstract][Full Text] [Related]
20. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides.
Abulafia-Lapid R; Elias D; Raz I; Keren-Zur Y; Atlan H; Cohen IR
J Autoimmun; 1999 Mar; 12(2):121-9. PubMed ID: 10047432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
